These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. VEGF-A/VEGFR-2 signaling plays an important role for the motility of pancreas cancer cells. Doi Y; Yashiro M; Yamada N; Amano R; Noda S; Hirakawa K Ann Surg Oncol; 2012 Aug; 19(8):2733-43. PubMed ID: 22207048 [TBL] [Abstract][Full Text] [Related]
50. SU11248 (sunitinib) directly inhibits the activity of mammalian 5'-AMP-activated protein kinase (AMPK). Laderoute KR; Calaoagan JM; Madrid PB; Klon AE; Ehrlich PJ Cancer Biol Ther; 2010 Jul; 10(1):68-76. PubMed ID: 20495370 [TBL] [Abstract][Full Text] [Related]
51. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity. Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863 [TBL] [Abstract][Full Text] [Related]
52. Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor β in the skin of mice with scleroderma-like features and prevents the development of the disease. Kavian N; Servettaz A; Marut W; Nicco C; Chéreau C; Weill B; Batteux F Arthritis Rheum; 2012 Jun; 64(6):1990-2000. PubMed ID: 22213155 [TBL] [Abstract][Full Text] [Related]
53. HGF/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumors. Shojaei F; Lee JH; Simmons BH; Wong A; Esparza CO; Plumlee PA; Feng J; Stewart AE; Hu-Lowe DD; Christensen JG Cancer Res; 2010 Dec; 70(24):10090-100. PubMed ID: 20952508 [TBL] [Abstract][Full Text] [Related]
54. Mononuclear gold(III) complexes with phenanthroline ligands as efficient inhibitors of angiogenesis: A comparative study with auranofin and sunitinib. Pavic A; Glišić BĐ; Vojnovic S; Warżajtis B; Savić ND; Antić M; Radenković S; Janjić GV; Nikodinovic-Runic J; Rychlewska U; Djuran MI J Inorg Biochem; 2017 Sep; 174():156-168. PubMed ID: 28675847 [TBL] [Abstract][Full Text] [Related]
56. Sunitinib suppresses tumor growth and metastases in a highly metastatic mouse mammary cancer model. Tanaka Y; Shibata MA; Morimoto J; Otsuki Y Anticancer Res; 2011 Apr; 31(4):1225-34. PubMed ID: 21508369 [TBL] [Abstract][Full Text] [Related]
57. Sunitinib: from charge-density studies to interaction with proteins. Malińska M; Jarzembska KN; Goral AM; Kutner A; Woźniak K; Dominiak PM Acta Crystallogr D Biol Crystallogr; 2014 May; 70(Pt 5):1257-70. PubMed ID: 24816095 [TBL] [Abstract][Full Text] [Related]
58. DNA binding of sunitinib: Spectroscopic evidence via circular dichroism and nuclear magnetic resonance. Kiss E; Mirzahosseini A; Hubert Á; Ambrus A; Őrfi L; Horváth P J Pharm Biomed Anal; 2018 Feb; 150():355-361. PubMed ID: 29287262 [TBL] [Abstract][Full Text] [Related]